Latest Sclerostin Stories
THOUSAND OAKS, Calif. and BRUSSELS, Jan.
Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation.
Kettlebell trainer Lorna Kleidman supports an article for Med Page Today which focuses on how the bone health of premenopausal women is improved through weekly bouts of moderate exercise.
A study to be published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that physical activity for premenopausal women is very effective in reducing sclerostin—a known inhibitor of bone formation.
Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells.
Study outcomes may also provide future direction for the development of drugs to combat osteoporosis, bone fractures.
The University of Colorado Boulder is involved with five different space science payloads ranging from antibody tests that may lead to new bone-loss treatments to an experiment to improve vaccine effectiveness for combating salmonella when Atlantis thunders skyward July 8 on the last of NASA's 135 space shuttle missions.
Researchers in the University of North Carolina at Chapel Hill/North Carolina State University Joint Department of Biomedical Engineering will be at the Kennedy Space Center for the last space shuttle launch of the NASA program as Atlantis departs for its final mission into Earth's orbit.
Thousand Oaks, Calif.
- Large; stout; burly.